Intercept Pharmaceuticals to Participate in Piper Sandler’s 34th Annual Healthcare Conference on December 1, 2022
MORRISTOWN, N.J., Nov. 22, 2022, Intercept Pharmaceuticals (Nasdaq: ICPT) announced that Jerry Durso, President and CEO, and Andrew Saik, CFO, will participate in a fireside chat at Piper Sandler’s 34th Annual Healthcare Conference on December 1, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MORRISTOWN, N.J., Nov. 22, 2022, Intercept Pharmaceuticals (Nasdaq: ICPT) announced that Jerry Durso, President and CEO, and Andrew Saik, CFO, will participate in a fireside chat at Piper Sandler’s 34th Annual Healthcare Conference on December 1, 2022. The chat is scheduled from 2:00 p.m. to 2:25 p.m. ET, and interested investors can register through their representatives to attend. Intercept specializes in developing therapeutics for progressive non-viral liver diseases, including primary biliary cholangitis and nonalcoholic steatohepatitis.
Details
News Market Reaction – ICPT
The recorded move for ICPT in the trading session of this news was +1.89%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MORRISTOWN, N.J., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer of Intercept, and Andrew Saik, Chief Financial Officer of Intercept, will participate in a fireside chat at Piper Sandler’s 34th Annual Healthcare Conference, taking place in person on Thursday, December 1, 2022. The Company will also conduct meetings with investors.
Intercept's fireside chat will take place from 2:00 p.m. – 2:25 p.m. ET. To view the fireside chat, please register for the Piper Sandler 34th Annual Healthcare Conference by contacting your representative. Investors attending the conference who wish to meet with the Intercept management team, please reach out to your representative or contact Nareg Sagherian.
About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH) and severe alcohol-associated hepatitis (sAH). For more information, please visit www.interceptpharma.com or connect with the Company on Twitter and LinkedIn.
Contact
For more information about Intercept, please contact:
Investor inquiries: investors@interceptpharma.com
Media inquiries: media@interceptpharma.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.